NYSE · traded in Congress
Bristol-Myers Squibb Company BMY
$61.64 +0.14 (+0.23%) Sep 25, 2026 4:00 AM ET
Market value$125.9B
P/E ratio-
Analyst target$68.00
52-week range-
Avg volume11,539,750
Dividend yield-
Chart
Congress trades in BMY
Members of Congress disclosed 1 transaction in BMY in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 05/07/2026 | Mike Kelly PA16 | Sale | $15,001 - $50,000 | 6/11/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView. Congressional trades parsed from official House filings. Market information, not investment advice.